press

Press03/06/2023

MULTIPLE MYELOMA: RESEARCH AND INNOVATIVE STUDIES IN FOCUS AT THE FOURTH EUROPEAN MYELOMA NETWORK CONGRESS

Between 20 and 22 April 2023, the world of Multiple Myeloma research will convene in Amsterdam, for three intense working days involving haematologists and clinical trials experts.
The event features 12 live sessions and the presentation of 73 abstracts. There will be four symposia, a sponsored lecture and five “Meet the experts” sessions. In addition, space will be dedicated to young researchers and to patient associations. Attendees will also have a chance to interact with speakers and moderators during lively debates and Q&A sessions.
The congress is promoted by the European EMN Network, headquartered in Rotterdam, and organized with the support of the Italian branch of the network, based in Turin.
Registration is via the site emn2023.com. Discounts apply for early registrations before 7 April.

The fourth Multiple Myeloma congress will be held in Amsterdam between Thursday 20 and Saturday 22 April. The location is the Beurs van Berlage, the historic building which housed the exchange market in the city centre.  The European Myeloma Network is a Europe-wide network whose objective is to achieve excellence in the research and treatment of Multiple Myeloma and related hematologic diseases.

Following two “virtual” editions, the EMN network is very excited to announce that this event will once again be held in person. As in the previous editions, the operation office set in Turin (Italy) is coordinating the whole event in collaboration with ER Congressi agency.

Registrations (see the form on the site emn2023) are already open, with “early bird” discounts available before 7 April 2023. It represents a further opportunity for young medics and researchers, who will be amongst the chief protagonists of the congress particularly as regards the poster area and oral presentations. Moreover, participants will earn access credits for CME (Continuing Medical Education) and EBAH (European Board for Accreditation in Haematology). The press area of the site also contains a dedicated channel for media accreditation.

The three-day programme provides a 12-session cycle, with an opportunity for the public to participate in a closing debate and to ask questions. Between 11.20 and 12.20 on Saturday 22 April, there will be a joint session with EHA (European Haematology Association), a not-for-profit, non-government organization whose mission is to promote excellence in patient care, research and haematology education. 

The congress sees the return of “Meet the Experts”, a series of five parallel, in-depth sessions with specific focus on therapies, practices, medicines and patient/family relationships. Three will be held on the Friday morning, a further two on the Saturday. Access is limited to 30 participants.

The congress will conclude with lectures and educational sessions and sponsored symposia. The area dedicated to posters will host seventy-three abstracts (nine of which have earned selection for oral presentation), and a session dedicated to projects and patients’ perspectives. 

The coordinators of the scientific programme are a Dutch contingent of Professors Pieter Sonneveld, Sonja Zweegman and Niels van de Donk, whilst the Italian group will be comprised of Professor Mario Boccadoro, Professor Francesca Gay and Doctor Roberto Mina.

Ten European countries are included in the EMN board: Austria with Prof. Heinz Ludwig, France with Prof. Philippe Moreau, Germany with Prof. Hermann Einsele. From Greece comes Prof. Meletios Athanasios Dimopoulos, whilst Italy is represented by the EMN vice-president Prof. Mario Boccadoro. EMN president Prof. Pieter Sonneveld is the Dutch delegate, whilst the Czech Republic is present in the form of Prof. Roman Hajek. Prof. Jesus Fernando San-Miguele joins from Spain, Prof. Gordon Cook from UK and Prof. Fredrik Schjesvold from Norway. In addition, speakers and moderators will join from Europe and beyond.
 
All information pertaining to the fourth European Multiple Myeloma Congress may be found on the official site and, subsequent to the event, on the dedicated EMN2023 app. Available to participants, it will feature information on the congress, on the various sessions and on the speakers involved.

Press
06/06/2019
EMN AT EHA SYMPOSIUM: BRINGING TOGETHER SCIENTIFIC COMMUNITY AND PHARMACEUTICAL INDUSTRY

In Amsterdam (June 13th 2019), a symposium chaired by Prof. Mario Boccadoro, Hematologist at the University of Turin, member of the European Myeloma Network and President of the Executive Committee of the EMN Research Italy Working Group, will deal with a very topical issue: the relationship between the scientific community and pharmaceutical companies – a highly relevant topic in the era of personalized medicine.

read more >
Press
02/16/2021
MULTIPLE MYELOMA: THE RESEARCH NEVER STOPS, WITH THE RESULTS ON VIEW AT THE SECOND CONGRESS OF THE EUROPEAN MYELOMA NETWORK

The Congress, initially scheduled for 2020 and postponed due to the pandemic, will now be a digital event. It will take place between 3 and 6 March and will connect haematologists and clinical trial experts across the continent.
The first edition, held at Turin’s Lingotto Congress Centre in April 2018, registered some 700 participants from 44 different countries.
Uniquely during this second edition, delegates will have the opportunity to interface directly with the speakers through instant chats.
The digital Congress is promoted by EMN International. It’s organized with the support of EMN Research Italy, the Italian operating branch of the EMN network, in collaboration with the ER Congressi agency.

read more >
Press
03/15/2022
THE THIRD EUROPEAN MYELOMA NETWORK CONFERENCE: WHAT IS NEW IN THE FIELD OF MULTIPLE MYELOMA

Between 6 and 9 April, the world of Multiple Myeloma research will convene for a virtual meeting involving haematologists and clinical trial experts from Europe and beyond.
This virtual congress is promoted by the European EMN network, headquartered in Rotterdam, with the support of the Italian team in Turin, and in collaboration with the ER Congressi agency.
New therapeutic approaches aimed at increasing survival and quality of life of myeloma patients will be addressed. Sponsored sessions will provide a valuable overview of the new molecules and innovative therapeutic approaches.

read more >

COOKIES DISCLAIMER

This website uses cookies to improve your browsing experience. By continuing to browse this website, you agree to our use of cookies. Read the privacy policy